Track banner

Now Playing

Realtime

Track banner

Now Playing

0:00

0:00

    Previous

    4 min read

    0

    0

    2

    0

    AI That's Smarter Than ChatGPT? DeepSeek's New Model Has Everyone Asking If U.S. Tech’s Days Are Numbered

    Explore the dawn of a new era in artificial intelligence as DeepSeek AI raises the stakes and challenges the status quo!

    8/7/2025

    Welcome to this edition of the newsletter, where we delve into groundbreaking advancements in technology and their implications for the future. As we witness the rise of impressive innovations like DeepSeek's new AI model, we invite you to consider: How will these developments redefine the landscape of artificial intelligence and impact global tech dominance? Please note that any investment-related information provided is for informational purposes only and does not constitute financial advice. Always consult with a financial advisor for investment decisions.

    🚨 Game-Changing Tech Update

    Hey investors and healthcare pros! Let's talk breakthroughs:

    • From the lab to your inbox: Lantern Pharma Inc. has unveiled their AI powerhouse, predictBBB.ai™! This cutting-edge AI module is designed to predict blood-brain barrier (BBB) permeability with an impressive 94% accuracy, providing a smart solution to the significant challenge of ensuring that small-molecule drugs can effectively reach the central nervous system (CNS).

    • Why this rocks the market: This innovation addresses a major obstacle in pharmaceutical development, where only 2-6% of small-molecule drugs can cross the BBB. With a robust performance boasting 95% sensitivity and 89% specificity, Lantern's platform is set to transform drug discovery processes, particularly for CNS diseases.

    • Don't miss the full scoop: Lantern Pharma Announces Public Release of Transformative, Advanced AI ...

    In addition, KredosAi is making strides in customer engagement technology. With a successful seed funding round led by Okapi Ventures, KredosAi plans to enhance its AI capabilities for telecommunications, auto lending, and finance sectors. This initiative aims to improve relationships with past-due customers through RCS messaging, aiming to ease payments and reduce churn.

    Furthermore, DeepSeek AI is capturing attention with its breakthrough R1 model that has surpassed the likes of ChatGPT. Founded by a co-founder of the quantitative hedge fund High-Flyer, this Chinese startup is setting a new bar for regulatory compliance and industry-specific applications in AI.

    For more details on the fundings and innovations in the health sector, check out these articles:

    1. KredosAi Seed Funding Closed for Scaling AI-Based Messaging Platform
    2. What is DeepSeek AI? China’s Breakthrough Innovation Challenging U.S. Tech Dominance!

    Stay tuned for more updates on the latest trends in healthcare technology!

    Subscribe to the thread
    Get notified when new articles published for this topic

    💡 Funding Flare

    Here's the latest in money moves:

    • Start the money machines: KredosAi raised funds to turbocharge AI for telecommunications, auto lending, and finance sectors. With a successful seed funding round led by Okapi Ventures, this startup is set to scale its innovative AI-driven customer engagement platform.

    • Why investors are all in: It's about enhancing customer relationships! By utilizing RCS messaging to improve interactions with past-due customers, KredosAi aims to ease payment processes and significantly reduce churn rates. This strategic investment not only bolsters engagement but also promises measurable returns on investment through targeted communication strategies. Learn more about this funding round and its potential impact on customer engagement here.

    • Also shaking up the funding scene, Lantern Pharma Inc. is making waves with their AI module predictBBB.ai™ designed for predicting blood-brain barrier permeability. This innovation not only addresses a critical challenge in pharmaceutical development but is also pivotal for enhancing drug discovery processes in central nervous system diseases. The anticipated growth in the blood-brain barrier technologies market is a testament to the importance of such advancements in healthcare. For a deeper dive into this revolutionary technology, check out the full announcement here.

    • To add to our global perspective, DeepSeek AI has emerged with impressive strides in AI, developing a model that surpasses popular applications like ChatGPT. Founded by a co-founder of the quantitative hedge fund High-Flyer, this startup signifies a significant shift in the AI landscape. You can explore more about DeepSeek’s innovations and what it means for the global tech market here.

    Stay informed on these dynamic moves within the funding landscape as they pave the way for innovations in healthcare and technology!

    🔍 Innovation Spotlight

    Spotlight on tech pushing limits:

    • AI like never before: DeepSeek AI's latest model, the DeepSeek R1, shows ChatGPT who's boss with category-leading innovation. This cutting-edge development emphasizes regulatory compliance and aims to cater specifically to industries like healthcare and finance, setting a new standard for AI applications.

    • Why this matters big time: We're talking regulatory focus with strong implications for the future of tech dominance in AI, as DeepSeek has risen to global popularity, challenging established players like ChatGPT and raising questions about the competitive landscape. Their focus on creating open-source large language models tailored to specific sectors enhances their reliability and impactful innovation in AI.

    • Dive deeper: What is DeepSeek AI? China’s Breakthrough Innovation Challenging U.S. Tech Dominance!

    In addition, Lantern Pharma Inc. is making waves with its AI-powered module predictBBB.ai™, designed to predict blood-brain barrier permeability with an impressive 94% accuracy. This advancement addresses a critical challenge in pharmaceutical development, where historically, only 2-6% of small-molecule drugs could effectively cross the blood-brain barrier. The incorporation of sophisticated AI technology not only enhances drug discovery for central nervous system diseases but also highlights the importance of innovative solutions in the healthcare sector.

    For further insights, check out: Lantern Pharma Announces Public Release of Transformative, Advanced AI ...

    Lastly, KredosAi is also making significant strides in enhancing customer engagement technologies through its successful seed funding round. With a focus on the telecommunications, auto lending, and finance sectors, KredosAi aims to improve customer relationships using AI-driven strategies that reduce churn and ease payments—a testament to the importance of innovation in user experience within these industries. Explore more: KredosAi Seed Funding Closed for Scaling AI-Based Messaging Platform.

    Stay tuned as these innovations unfold, reshaping the future of technology in healthcare and beyond!